Your browser doesn't support javascript.
loading
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
González-Cordón, Ana; Assoumou, Lambert; Moyle, Graeme; Waters, Laura; Johnson, Margaret; Domingo, Pere; Fox, Julie; Stellbrink, Hans-Jürgen; Guaraldi, Giovanni; Masiá, Mar; Gompels, Mark; De Wit, Stephane; Florence, Eric; Esser, Stefan; Raffi, François; Behrens, Georg; Pozniak, Anton; Gatell, Jose M; Martínez, Esteban.
Afiliação
  • González-Cordón A; Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Assoumou L; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Moyle G; INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Sorbonne Université, Paris, France.
  • Waters L; Consultant Physician in HIV Medicine, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
  • Johnson M; Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK.
  • Domingo P; Senior Consultant Physician in Thoracic Medicine, Royal Free London NHS Foundation Trust, London, UK.
  • Fox J; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Stellbrink HJ; Senior Consultant at Infectious Diseases Unit, Hospital de Sant Pau, Barcelona, Spain.
  • Guaraldi G; HIV Research Lead, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Masiá M; Professor of Medicine, Infektionsmedizinisches Centrum, Hamburg, Germany.
  • Gompels M; Professor of Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • De Wit S; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Florence E; Professor of Medicine, Hospital General Universitario de Elche, Elche, Spain.
  • Esser S; Clinical Lead for Allergy, Immunology and HIV, North Bristol NHS Trust, Bristol, UK.
  • Raffi F; Professor of Medicine, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium.
  • Behrens G; Head of the HIV Clinic, Universitair Ziekenhuis Antwerpen, Antwerp, Belgium.
  • Pozniak A; Academic Director, Universitätsklinikum, Essen, Germany.
  • Gatell JM; Professor of Infectious Diseases, Centre Hospitalier Universitaire, Nantes, France.
  • Martínez E; Profesor of Immunology, Medizinische Hochschule, Hannover, Germany.
J Antimicrob Chemother ; 78(9): 2361-2365, 2023 09 05.
Article em En | MEDLINE | ID: mdl-37539492
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Doenças Cardiovasculares / Infecções por HIV / Inibidores da Protease de HIV / Fármacos Anti-HIV Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Doenças Cardiovasculares / Infecções por HIV / Inibidores da Protease de HIV / Fármacos Anti-HIV Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha